RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer

Recent high-throughput studies revealed recurrent RUNX1 mutations in breast cancer, specifically in oestrogen receptor-positive (ER(+)) tumours. However, mechanisms underlying the implied RUNX1-mediated tumour suppression remain elusive. Here, by depleting mammary epithelial cells of RUNX1 in vivo a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Nat Commun
Main Authors: Chimge, Nyam-Osor, Little, Gillian H., Baniwal, Sanjeev K., Adisetiyo, Helty, Xie, Ying, Zhang, Tian, O'Laughlin, Andie, Liu, Zhi Y., Ulrich, Peaches, Martin, Anthony, Mhawech-Fauceglia, Paulette, Ellis, Matthew J., Tripathy, Debu, Groshen, Susan, Liang, Chengyu, Li, Zhe, Schones, Dustin E., Frenkel, Baruch
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4773428/
https://ncbi.nlm.nih.gov/pubmed/26916619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms10751
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki